Cynata Therapeutics Ltd V.CYP

Primary Symbol: CYYNF

Healthcare Biotechnology

Cynata Therapeutics Limited is an Australia-based clinical-stage stem cell and regenerative medicine company. The Company is focused on the development of therapies based on Cymerus, which is a therapeutic stem cell platform technology. Cymerus uses induced pluripotent stem cells and a precursor cell, mesenchymoangioblast (MCA) to manufacture cell therapy products, including mesenchymal stem cells, on a commercial scale. Its lead product candidate, CYP-001, is under Phase I trial and developed for the treatment of steroid-resistant acute graft-versus-host disease (GvHD). Clinical trials of Cymerus products in osteoarthritis, which is under Phase III trial, and diabetic foot ulcers (DFU) are ongoing. In addition, the Company has demonstrated the utility of its Cymerus technology in preclinical models of various diseases, including critical limb ischaemia, idiopathic pulmonary fibrosis, asthma, heart attack, sepsis, acute respiratory distress syndrome and other.

OTCPK:CYYNF - Post by User

Cynata Therapeutics Ltd

<< Previous

Bullboard Posts

Next >>

Post by GarryJan1on Jul 08, 2020 11:58am

137 Views

Post# 31239700

Looks like our neighbor is also ready for a breakout as

well with 17 x million on the bid at 3 cents. Remember SPMT has a large amount of our minerals on there property from the surface. Probably enough for another mine. LOOK AT THOSE GRADES below.

Spearmint Real TiQuote: As Of July 8, 2020 11:50:45 AM ET

Last Price: $0.035 Change: $0.00 Bid Lots:17,263 Bid: $0.03 Ask: $0.035 Ask Lots:734 Volume:392,000

I own both.

Cannot view this image? Visit: https://orders.newsfilecorp.com/files/4360/58245_acb65bbe54b6aa35_002.jpg